Rasagiline orally disintegrating compositions
OwnerShulamit Patashnik, Daniella Licht +1inventors
InventorsShulamit Patashnik, Daniella Licht, Adrian Gilbert
Life of this patent
Estimating the term…
Loading patent…
OwnerShulamit Patashnik, Daniella Licht +1inventors
InventorsShulamit Patashnik, Daniella Licht, Adrian Gilbert
Estimating the term…
This invention provides a solid pharmaceutical composition comprising rasagiline or a pharmaceutically acceptable salt of rasagiline, and particles having a non-filamentous microstructure of at least two sugar alcohols. This invention also provides a solid pharmaceutical composition comprising rasagiline or a pharmaceutically acceptable salt of rasagiline, a mixture of a disintegrant, a flow agent and particles having a non-filamentous microstructure of at least two sugar alcohols, a supplemental sugar alcohol, a supplemental flow agent, and a supplemental disintegrant. This invention further provides a method of treating a subject afflicted with Parkinson's disease comprising administering to the subject a therapeutically effective amount of the solid pharmaceutical composition, thereby treating the subject. Finally, this invention provides a process of making such solid pharmaceutical compositions.
A solid pharmaceutical composition comprising rasagiline or a pharmaceutically acceptable salt of rasagiline, and particles having a non-filamentous microstructure of at least two sugar alcohols.
3-4. (canceled)
(canceled)
8-11. (canceled)
13-15. (canceled)
(canceled)
(canceled)
21-22. (canceled)
28-29. (canceled)
A solid pharmaceutical composition comprising
32-65. (canceled)
68-69. (canceled)
A solid pharmaceutical composition comprising
71-87. (canceled)
Dependencies are inferred from the claim text.